AgiBot Lands Multimillion-Yuan Order from Fulin Precision, Marking Breakthrough in Industrial Embodied Intelligence at Scale | BlueRun Ventures Portfolio Headlines
China's First Large-Scale Commercial Order for Industrial Embodied Robots
China's First Large-Scale Commercial Order for Industrial Embodied Robots
Define the next-generation TCG ecosystem.
Continuing to explore general-purpose robots, the ultimate goal of AGI
The business world has never gone easy on "good technology."
Conversations on Innovation, Venture Capital, and Creation
Ditching the "One-Size-Fits-All" for Specialized Expertise
Counselor on Vitality
Delivering more competitive Chinese solutions for the global medical aesthetics market
The evening breeze of a summer night is the sound of the future rushing in.
For AI drug discovery companies, it's not enough to possess proprietary core technologies — they must also embed themselves deeply into the practical scenarios of pharmaceutical R&D, driving those technologies toward real-world implementation and commercial translation.